Results 191 to 200 of about 15,642,944 (272)

Development of a Genetically Characterized Panel of 15 Mucosal Melanoma Cell Lines for the Preclinical Evaluation of Targeted Therapies in Human and Veterinary Medicine

open access: yesPigment Cell &Melanoma Research, Volume 39, Issue 6, November 2026.
Development and genetic characterisation of canine mucosal melanoma cell lines for in vitro and in vivo drug screening. ABSTRACT Mucosal melanoma (MM) is a rare and aggressive cancer in humans, with limited therapeutical options and no faithful models for preclinical research.
Caroline Confais   +11 more
wiley   +1 more source

Update of the Scientific Opinion on the risks for animal and public health related to the presence of Alternaria toxins in feed and food

open access: yesEFSA Journal, Volume 24, Issue 11, November 2026.
Abstract The European Commission requested the EFSA Panel on Contaminants in the Food Chain (CONTAM Panel) to update its 2011 Scientific Opinion on the risks to animal and public health related to the presence of Alternaria toxins in feed and food.
EFSA Panel on Contaminants in the Food Chain (CONTAM)   +30 more
wiley   +1 more source

IID432, a parasite-selective topoisomerase II inhibitor, achieves rapid single-dose parasite clearance in a murine chronic Chagas model. [PDF]

open access: yesProc Natl Acad Sci U S A
Saldivia M   +32 more
europepmc   +1 more source

Endothelial Matrin‐3 Limits Cellular Senescence and Lipid Dysregulation to Protect Against Murine Atherosclerosis

open access: yesThe FASEB Journal, Volume 40, Issue 20, 31 October 2026.
Endothelial Matrin‐3 suppresses cellular senescence and protects against atherosclerosis. Matrin‐3 deficiency induces endothelial senescence, mitochondrial dysfunction, and activation of p53‐, cell cycle‐, and senescence‐related pathways. In atherosclerosis‐prone mice, endothelial Matrin‐3 deletion promotes atherosclerotic lesion formation and disrupts
Xiao Cheng   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy